Supernus: Fourth Quarter Financial Overview
Supernus Pharmaceuticals Reports Fourth Quarter Financial Results
Supernus Pharmaceuticals Inc., headquartered in Rockville, Maryland, announced on Tuesday that it recorded a net loss of $4.1 million for the fourth quarter.
The company reported a loss of $0.07 per share for the quarter. When excluding amortization and one-time expenses, adjusted earnings came to $0.92 per share.
During the same period, Supernus generated $211.6 million in revenue.
For the entire fiscal year, the company posted a total loss of $38.6 million, translating to $0.68 per share, with annual revenue reaching $719 million.
Looking ahead, Supernus anticipates its revenue for the upcoming year will fall between $840 million and $870 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Top 15 Perpetual DEXES by Weekly Trading Volume
Market News: Another Loud Bang Heard in Dubai, UAE
Crypto Market Prices Fall as War Tensions Escalate, Trump Confirms US Combat Operations in Iran
Is This the Next Breakout? Top Low Market Cap Crypto Presale Tokens for 2026

